Remdesivir Use and Hospital Length of Stay—The Paradox of a Clinical Trial vs Real-Life Use

Overview of attention for article published in JAMA Network Open, July 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

news: 3 news outlets
blogs: 2 blogs

twitter: 7 X users
reddit: 1 Redditor

Readers on

mendeley: 19 Mendeley

So far, Altmetric has seen 3 news stories from 3 outlets.

The Fake News that FDA Approved the Vaccines Is Made Clear in the Letter. Emergency Use Authorization (EUA) Prevails - Global Research

Globalresearch, 25 Aug 2021

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner…

COVID-19 remdesivir study finds long hospital stay, but context matters

Centre for Disease Research and Policy, 15 Jul 2021

Remdesivir, the only antiviral fully approved for COVID-19 treatment by the US Food and Drug Administration (FDA), was…

Large Remdesivir Study Finds No COVID-19 Survival Benefit

Medscape, 15 Jul 2021

Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.